November 5, 2019
SCOR Global Life has made a strategic investment in BioSerenity, a French medical solutions company that aims to optimize the patient pathways in several chronic diseases through the design of connected devices, end-t
This publication presents some global information on kidney diseases, the definitions and basic notions, protective treatments, renal replacement therapies, disease progression information as well as proposed underwri
October 28, 2019
In order to achieve the objectives of the “Quantum Leap” strategic plan, SCOR Global Life evolves its organisation and announces promotions in its Global Markets team.
SOLEM supports our clients throughout the world to assess risks, including a dedicated Claims management section.
The growing use of economic-value-based metrics will greatly benefit longstanding reinsurers, writes Denis Kessler, Chairman and CEO of SCOR, for the CEO Forum
Investor Day 2019: presentation
At its annual Investor Day in Paris, SCOR presents its new strategic plan, “Quantum Leap”.
September 2, 2019
J.C. Brueckner, CEO of SCOR Global Life Americas, argues that reinsurers need experts with cross-functional knowledge and need to develop a deeper understanding of their end-clients.
Why and how cancer of the cervix is set to become rare and will likely be eliminated in Australia.
SCOR announces the public release and the filing with the Autorité des marchés financiers of its interim financial report for the six months ended June 30, 2019
Presentation
